New York, NY (PRWEB) December 07, 2012
The DrugRisk Resource Center, a patient awareness group, is alerting women prescribed the contraceptive NuvaRing that experts have linked the devices to blood clots and the FDA has received thousands of reports of complications among users.
According to the Adverse Events Report on December 5th tracking FDA AERS reports through June 30, 2012, the agency has received more than 5,000 reports of complications among women using NuvaRing devices.*
Most common among these were 1,064 reports of pulmonary embolism and 730 reports of deep vein thrombosis, with hospitalization resulting in 30% of cases.
The news comes as the 2012 Statistical Analysis from the Judicial Panel on MultiDistrict Litigation reports as many as 1,028 patients have filed NuvaRing lawsuits, which have been moved to a special federal court in Missouri.** The formal case is known as In re: NuvaRing Products Liability Litigation, No. 08-md-1964, JPML, Eastern District Missouri.
Anyone who suffered blood clots, stroke, DVT or pulmonary embolism after using NuvaRing is urged to contact the DrugRisk Resource Center or speak with a lawyer about their legal rights as soon as possible.
U.S. District Judge Rodney Sippel, who will preside over the federal cases, recently issued an order postponing the start of trials to July 8, 2013.*** The later trial dates could give those who have yet to learn their options after an injury more time to do so.
Experts have related vaginal rings like NuvaRing to higher blood clot risks than with traditional birth control pills.
The British Medical Journal published a Danish study on May 10, 2012 linking vaginal rings like NuvaRing to as much as a 90% increased risk of blood clots over oral contraceptives. On June 14, 2012, the New England Journal of Medicine also published a study finding vaginal ring contraceptives could relate to a 2.5 to 3-fold increased risk of blood clots.
The DrugRisk Resource Center urges anyone affected by blood clots, stroke, DVT or pulmonary embolism after using NuvaRing to learn their legal rights.
Due to the specialized nature of federal MDL drug injury cases, the DrugRisk Center only recommends lawyers and law firms who have already handled NuvaRing lawsuits.
For more information on the research, side effects and litigation news related to NuvaRing and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.
***Order # 1423, Novenber 20, 2012, Case: 4:08-md-01964-RWS